Samuel Grigg

12PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsLiquid biopsiesPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 07, 2026
Durable response to salvage gilteritinib, allogeneic stem cell rescue and maintenance therapy in relapsed AML with a FLT3 N676K variant.

|Dec 22, 2024
Genomic mechanisms associated with resistance to PDL1-blockade in a patient with mantle cell lymphoma.

Samuel Grigg, Stephen Lade, Georgina Ryland

|Nov 19, 2024
Rates of discordant CD20 status by flow cytometry and immunohistochemistry in B-ALL.

Samuel Grigg, Melissa Ng Liet Hing, Kah Lok Chan

|May 09, 2024
Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high.

Samuel Grigg, Adrian Minson, Elizabeth Prins

|Sep 11, 2019
Angiotensin- neprilysin inhibitors: should we initiate them in hospital for patients with acute decompensated heart failure?

Sam E Grigg

|Jun 12, 2019
Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply.

Sam E Grigg, Gino L Sarri, Paul J Gow

Pageof 2

Frequent Collaborators

4 joint publications

Neville Yeomans

1 joint publications

Andrew Grigg

1 joint publications

Carl Heneghan

1 joint publications

Gino L Sarri